Keyphrases
N-3 FA
100%
Oral nutritional Supplements
75%
Colon Tissue
50%
Perioperative Care
50%
Omega-3 Fatty Acids
50%
Colorectal Cancer
50%
Colorectal Cancer Surgery
26%
Outcomes after Surgery
25%
Muscular Layer
21%
Before Surgery
20%
Adjuvant Chemotherapy
18%
Colonic mucosa
14%
Acid Groups
14%
Recurrent Disease
12%
Postoperative Complications
12%
Disease Risk
12%
5-year Survival
12%
Immune Function
7%
Tissue Fatty Acid Profile
7%
Disease Stage
6%
After Surgery
6%
Cumulative Incidence
6%
Metastatic Colorectal Cancer (mCRC)
6%
Age-stage
6%
Elective Resection
6%
Hazard Ratio
6%
Relative Risk
6%
Twice Daily
6%
Colorectal Cancer Recurrence
6%
Survival Benefit
6%
Control Hazard
6%
Postoperative Outcomes
6%
Complication after Surgery
6%
High Mortality
6%
Medicine and Dentistry
Colorectal Cancer
100%
Omega-3 Fatty Acid
100%
Cancer Surgery
75%
Randomized Clinical Trial
50%
Nutrition Supplement
50%
Adjuvant Chemotherapy
37%
Supplementation
25%
Postoperative Complication
25%
Recurrent Disease
25%
Diseases
12%
Hazard Ratio
12%
Cumulative Incidence
12%
Metastatic Colorectal Cancer
12%
Surgery
12%
Survival Rate
12%
Cancer Recurrence
12%
Overall Survival
12%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Cancer
100%
Omega-3 Fatty Acid
100%
Nutrition Supplement
62%
Randomized Clinical Trial
50%
Chemotherapy
37%
Postoperative Complication
25%
Recurrent Disease
25%
Metastatic Colorectal Cancer
12%
Docosahexaenoic Acid
12%
Overall Survival
12%
Survival Rate
12%
Disease
12%
Cancer Recurrence
12%
Docosapentaenoic Acid
6%